Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Dry

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomasMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2016
Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Plos One|February 25, 2017
Community recommendations on biobank governance: Results from a deliberative community engagement in CaliforniaSarah M Dry, Sarah B Garrett, Barbara A Koenig, et al.
Oncotarget|November 5, 2017
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Anticancer Research|July 26, 2017
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell LinesKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 12, 2016
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
American Journal of Clinical Oncology|August 23, 2019
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma CenterDanielle S Graham, Tara A Russell, Mark A Eckardt, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomasMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2016
Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Plos One|February 25, 2017
Community recommendations on biobank governance: Results from a deliberative community engagement in CaliforniaSarah M Dry, Sarah B Garrett, Barbara A Koenig, et al.
Oncotarget|November 5, 2017
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Anticancer Research|July 26, 2017
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell LinesKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 12, 2016
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
American Journal of Clinical Oncology|August 23, 2019
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma CenterDanielle S Graham, Tara A Russell, Mark A Eckardt, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.
Pageof 15